WS #12274

From 500 msgs · 20 key-dev

Intuitive Surgical shares fell 10% after Q2 results showed US da Vinci procedure growth slowing to 12%, weakest in four years; GLP-1 drugs and insurance uncertainty weigh on demand.

ISRG plunges on weak da Vinci procedure growth

Intuitive Surgical shares fell 10% after Q2 results showed US da Vinci procedure growth slowing to 12%, weakest in four years; GLP-1 drugs and insurance uncertainty weigh on demand.

Full world state #12274 →